1)Rowinsky EK, Cazenave LA, Donehower RC:Taxol:a novel investigational antimicrotubule agent. J Natl Cancer Inst 82:1247-1259, 1990
2)Joshi MM, Garretson BR:Paclitaxel maculopathy. Arch Ophthalmol 125:709-710, 2007
3)Smith SV, Benz MS, Brown DM:Cystoid macular edema secondary to albumin-bound paclitaxel therapy. Arch Ophthalmol 126:1605-1606, 2008
4)有岡 仁:がんの化学療法 最新治療コンセンサス パクリタキセルとドタキセル.医学のあゆみ215:366-371
5)加藤秀紀・尾本 聡・久保寛之・他:ドタキセルによって涙道閉塞をきたした3例.臨眼58:1463-1466,2004
6)Hofstra LS, de Vries EG, Willemse PH:Ophthalmic toxicity following paclitaxel infusion. Ann Oncol 8:1053, 1997
. J Clin Oncol 12:1741-1742, 1994
8)Capri G, Munzone E, Tarenzi E et al:Optic nerve disturbances:a new form of paclitaxel neurotoxicity. J Natl Cancer Inst 86:1099-1101, 1994
9)Teitelbaum BA, Tresley DJ:Cystic maculopathy with normal capillary permeability secondary to docetaxel. Optom Vis Sci 80:277-279, 2003
10)伊藤 正・奥田正俊:抗癌剤パクリタキセル使用中に囊胞様の黄斑症を呈した1例.日眼会誌114:23-27,2010
11)Amos LA, Lowe J:How Taxol stabilizes microtubule structure. Chem Biol 6:R65-69, 1999
12)Goldstein LS:Kinesin molecular motors:transport pathways, receptors, and human disease. Proc Natl Acad Sci USA 98:6999-7003, 2001
13)高橋伸通・小國 務・堀 暢英・他:パクリタキセル投与中に黄斑部囊胞様変化をきたした1例.眼科54:1819-1824,2012
14)Matsuoka N, Hasebe H, Mayama T et al:Sub-tenon injections of triamcinolone acetonide had limited effect on cystoid macular edema secondary to nanoparticle albumin-bound-paclitaxel(Abraxane). Case Rep Ophthalmol Med:181269, 2015
15)山崎厚志・金田周三・三宅賢一郎・他:抗癌剤パクリタキセルによる両眼性囊胞様黄斑症が継続投与中に消失した1例.眼臨紀5:866-877,2012
16)Telander DG, Sarraf D:Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol 22:151-153, 2007
17)Koo NK, Kim YC:A case of paclitaxel-induced maculopathy treated with methazolamide. Korean J Ophthalmol 26:394-397, 2012
18)Moldow B, Sander B, Larsen M et al:Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest Ophthalmol Vis Sci 40:1770-1775, 1999